Viewing Study NCT01573468


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-28 @ 2:28 AM
Study NCT ID: NCT01573468
Status: UNKNOWN
Last Update Posted: 2012-07-24
First Post: 2012-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer
Sponsor: Genta Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module